日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

AXL-SHC1 signaling axis mediates adaptive resistance to HER2-targeted tyrosine kinase inhibitors in HER2-aberrant lung and gastric cancers

AXL-SHC1信号轴介导HER2异常肺癌和胃癌对HER2靶向酪氨酸激酶抑制剂的适应性耐药

Ishida, Masaki; Yamada, Tadaaki; Katayama, Yuki; Kawachi, Hayato; Sawada, Ryo; Nakamura, Ryota; Hirai, Soichi; Matsui, Yohei; Morimoto, Kenji; Onoi, Keisuke; Nakamura-Sasada, Aosa; Horinaka, Mano; Sakai, Toshiyuki; Sakakida, Tomoki; Doi, Toshifumi; Yasumoto, Kazuo; Goto, Yasuhiro; Furuya, Naoki; Taniguchi, Hirokazu; Ogino, Hirokazu; Takayuki, Nakano; Chihara, Yusuke; Fukuda, Koji; Taniguchi, Hiroaki; Uehara, Hisanori; Yano, Seiji; Tokuda, Shinsaku; Takayama, Koichi

Correction: A SYK/SHC1 pathway regulates the amount of CFTR in the plasma membrane

更正:SYK/SHC1通路调节质膜中CFTR的含量。

Loureiro, Cláudia Almeida; Pinto, Francisco R; Barros, Patrícia; Matos, Paulo; Jordan, Peter

HPIP is an essential scaffolding protein running through the EGFR-RAS-ERK pathway and drives tumorigenesis

HPIP 是通过 EGFR-RAS-ERK 通路运行的重要支架蛋白,可促进肿瘤发生

Qiwei Jiang, Deyu Zhang, Juan Liu, Chaoyang Liang, Ronghui Yang, Cheng Zhang, Jun Wu, Jing Lin, Tianxing Ye, Lihua Ding, Jianbin Li, Shan Gao, Binghui Li, Qinong Ye

YES1 Kinase Mediates the Membrane Removal of Rescued F508del-CFTR in Airway Cells by Promoting MAPK Pathway Activation via SHC1

YES1 激酶通过 SHC1 促进 MAPK 通路激活,介导气道细胞中获救的 F508del-CFTR 的膜去除

Patrícia Barros, Ana M Matos, Paulo Matos, Peter Jordan

EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation

EGFR 配体通过 BIN3 上调抑制侵袭,使 EGFR 在 EGFR 扩增的胶质母细胞瘤中从致癌基因转变为肿瘤抑制因子

Gao Guo, Ke Gong, Nicole Beckley, Yue Zhang, Xiaoyao Yang, Rati Chkheidze, Kimmo J Hatanpaa, Tomas Garzon-Muvdi, Prasad Koduru, Arifa Nayab, Jennifer Jenks, Adwait Amod Sathe, Yan Liu, Chao Xing, Shwu-Yuan Wu, Cheng-Ming Chiang, Bipasha Mukherjee, Sandeep Burma, Bryan Wohlfeld, Toral Patel, Bruce Mi

SHC1 Promotes Lung Cancer Metastasis by Interacting with EGFR

SHC1通过与EGFR相互作用促进肺癌转移

Yang, Pan; Li, Wei; Li, Xiaoping

The increased expression and aberrant methylation of SHC1 in non-small cell lung cancer: Integrative analysis of clinical and bioinformatics databases

非小细胞肺癌中SHC1表达增加和异常甲基化:临床和生物信息学数据库的整合分析

Yicheng Liang,Yangyang Lei,Minjun Du,Mei Liang,Zixu Liu,Xingkai Li,Yushun Gao

Hepatic Knockdown of Endothelin Type A Receptor (ETAR) Ameliorates Hepatic Insulin Resistance and Hyperglycemia Through Suppressing p66Shc-Mediated Mitochondrial Fragmentation in High-Fat Diet-Fed Mice

肝脏内皮素 A 型受体 (ETAR) 的敲低可通过抑制高脂饮食喂养小鼠的 p66Shc 介导的线粒体碎裂来改善肝脏胰岛素抵抗和高血糖症

Li Feng #, Songhua Wang #, Feng Chen #, Cheng Zhang, Qiao Wang, Yuting Zhao, Zifeng Zhang

DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1

DEPDC1B通过靶向SHC1在膀胱癌发展中发挥肿瘤促进作用。

Lai, Chin-Hui; Xu, Kexin; Zhou, Jianhua; Wang, Mingrui; Zhang, Weiyu; Liu, Xianhui; Xiong, Jie; Wang, Tao; Wang, Qi; Wang, Huanrui; Xu, Tao; Hu, Hao

A SYK/SHC1 pathway regulates the amount of CFTR in the plasma membrane

SYK/SHC1 通路调节质膜中 CFTR 的数量

Cláudia Almeida Loureiro, Francisco R Pinto, Patrícia Barros, Paulo Matos, Peter Jordan